Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients
T2DM (Type 2 Diabetes Mellitus), Continuous Glucose Monitoring
About this trial
This is an interventional supportive care trial for T2DM (Type 2 Diabetes Mellitus)
Eligibility Criteria
Inclusion Criteria:
- 18 years or older with a diagnosis of T2DM with a scheduled office visit with primary care provider within the next 4 weeks
- Last 2 HbA1c values between 7.5 - 10% measured in the last 12 months
- Treated with non-insulin therapies or therapeutic lifestyle changes
- Never worn professional CGM or have not worn in last 12 months
- Willing to perform requirements needed for professional CGM
Exclusion Criteria:
1. Current or previous treatment with any insulin within 3 months at baseline
Sites / Locations
- East Tennessee State University
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
3-Month iPro2 Professional CGM
6-Month iPro2 Professional CGM
Professional CGM measures interstitial glucose every 5 minutes via a glucose-oxidase-impregnated membrane during a 3 day period. The patient wearing professional CGM is blinded to the repeated measurements and the data is stored for retrospective analysis.
Professional CGM measures interstitial glucose every 5 minutes via a glucose-oxidase-impregnated membrane during a 3 day period. The patient wearing professional CGM is blinded to the repeated measurements and the data is stored for retrospective analysis.